Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells?

Medical Hypotheses

Volumn 72, Issue 1, 2009, Pages 55-57

  Ali, Bassam R ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CYSTIC FIBROSIS; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GENE MUTATION; HUMAN; LIFE EXPECTANCY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FOLDING; QUALITY CONTROL; QUALITY OF LIFE; RISK ASSESSMENT;

APOPTOSIS; CELL SURVIVAL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIABETES MELLITUS; ENDOPLASMIC RETICULUM; HUMANS; INSULIN-SECRETING CELLS; PANCREAS; SEQUENCE DELETION;

EID: 56249088227     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.07.058     Document Type: Article

References (29)

1. Araki E., Oyadomari S., and Mori M. Endoplasmic reticulum stress and diabetes mellitus. Int Med 42 (2003) 7-14
2. Brennan A.L., Geddes D.M., Gyi K.M., and Baker E.H. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 3 (2004) 209-222
3. Elborn J.S., Shale D.J., and Britton J.R. Cystic fibrosis: Current survival and population estimates to the year 2000. Thorax 46 (1991) 881-885
4. Chen Y., Bellamy W.P., Seabra M.C., Field M.C., and Ali B.R. ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome. Hum Mol Genet 14 (2005) 2559-2569
5. Couce M., O'Brien T.D., Moran A., Roche P.C., and Butler P.C. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 81 (1996) 1267-1272
6. 3-secretion in cystic fibrosis. Pediatr Res 16 (1982) 554-557
7. Hamdi I., Payne S.J., Barton D.E., McMahon R., Green M., Shneerson J.M., et al. Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus. Clin Genet 43 (1993) 186-189
8. Harding H., Zeng H., Zhang Y., Jungreis R., Chung P., Plesken H., et al. Diabetes mellitus and exocrine pancreatic dysfunction in Perk-/- mice reveals a role for translational control in survival of secretory cells. Mol Cell 7 (2001) 1153-1163
9. Hayden M.R., and Tyagi S.C. Islet redox stress: The manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. J Pancreas 3 (2002) 86-108
10. Iannucci A., Mukai K., Johnson D., and Burke B. Endocrine pancreas in cystic fibrosis: An immunohistochemical study. Hum Pathol 15 (1984) 278-284
11. Janson J., Ashley R.H., Harrison D., McIntyre S., and Butler P.C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48 (1999) 491-498
12. Koch C., Cuppens H., Rainisio M., Madessani U., Harms H., Hodson M., et al. Investigators of the ERCF. European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 31 (2001) 1-12
13. Koch C., Rainisio M., Madessani U., Harms H.K., Hodson M.E., Mastella G., et al. Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European epidemiologic registry of cystic fibrosis. Pediatr Pulmonol 32 (2001) 343-350
14. Kopelman H., Corey M., Gaskin K., Durie P., Weizman Z., and Forstner G. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 95 (1988) 349-355
15. Leroux L., Desbois P., Lamotte L., Duvillie B., Cordonnier N., Jackerott M., et al. Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 50 Suppl 1 (2001) S150-S153
16. Mackie A.D., Thornton S.J., and Edenborough F.P. Cystic fibrosis-related diabetes. Diabet Med 20 (2003) 425-436
17. Marshall B.C., Butler S.M., Stoddard M., Moran A.M., Liou T.G., and Morgan W.J. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 146 (2005) 681-687
18. McCracken A.A., and Brodsky J.L. Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). Bioessays 25 (2003) 868-877
19. Moran A. Cystic fibrosis-related diabetes: An approach to diagnosis and management. Pediatr Diabetes 1 (1998) 41-48
20. Moran A., Hardin D., Rodman D., Allen H.F., Beall R.J., Borowitz D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report. Diabetes Res Clin Pract 45 (1999) 61-73
21. Oyadomari S., Araki E., and Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic ß-cells. Apoptosis 7 (2002) 335-345
22. Polychronakos C. Early onset diabetes mellitus. Tip or iceberg?. Pediatr Diabetes 5 (2004) 171-173
23. Rosenecker J., Eichler I., Kuhn L., Harms H.K., and von der Hardt H. Genetic determination of diabetes mellitus in patients with cystic fibrosis. Multicenter Cystic Fibrosis Study Group. J Pediatr 127 (1995) 441-443
24. Scheuner D., Song B., McEwen E., Gillespie P., Saunders T., Bonner-Weir S., et al. Translational control is required for the unfolded protein response and in-vivo glucose homeostasis. Mol Cell 7 (2001) 1165-1176
25. Soejima K., and Landing B.H. Pancreatic islets in older patients with cystic with and without diabetes mellitus: Morphometric and immunocytologic studies. Pediatr Pathol 6 (1986) 25-46
26. Rutkowski D.T., and Kaufman R.J. A trip to the ER: Coping with stress. Trends Cell Biol 14 (2004) 20-28
27. Wang J., Takeuchi T., Tanaka S., Kubo S.K., Kayo T., Lu D., et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103 (1999) 27-37
28. Welsh M.J., Tsui L.C., Boat T.F., and Beaudet A.L. Cystic fibrosis. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular basis of inherited disease (1995), McGraw-Hill, New York p. 3799
29. Yoshioka M., Kayo T., Ikeda T., and Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46 (1997) 887-894